OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
The prevalence of Diabetic Peripheral Neuropathy is 29–49% in people with Diabetes Mellitus, up to 50% of them develop Neuropathic Pain. The reasons for this are not completely understood and this heterogeneity cannot be always captured by a single molecular assay. Studying the molecular changes at the level of genetic variation; the gene and protein expression; the quantity of metabolites and serum biomarkers can reveal composite signatures explaining the heterogeneity of the disease. I will discuss how we can utilise multi-omics data integration and analysis to discover composite biomarkers associated with the presence and intensity of Neuropathic Pain
